Thiogenesis Receives Final EU Clearance of CTA to Initiate its Phase 2 Clinical Trial in MELAS
January 27, 2025) - Thiogenesis Therapeutics, and Corp. (TSXV: TTI) ("Thiogenesis" or the "Company"), a clinical-stage biotechnology company developing disulfides that drive the production of ...
pharmaphorum2d
Alnylam’s vutrisiran aces ATTR cardiomyopathy readout
Additionally, it hit the mark on a range of secondary endpoints, showing improvement over placebo on the 6-minute walk test (6-MWT), Kansas City Cardiomyopathy Questionnaire (KCCQ), and New York ...
Medscape1d
Pulmonary Rehabilitation* Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines
6 MWT = 6-min walk test; PFT = pulmonary function test; POD = perception of dyspnea. See Table 3 for abbreviations not used in the text. *OP = outpatient; ADL = activities of daily living ...